Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Tango Therapeutics is a precision oncology company focused on developing targeted cancer therapies by exploiting genetic vulnerabilities such as tumor suppressor gene loss. Its pipeline includes novel small molecules targeting PRMT5 and CoREST, aimed at genetically defined patient populations. The company leverages advanced target discovery platforms, collaborates with industry partners, and relies on third-party manufacturing to deliver innovative treatments for cancers with high unmet medical needs.
This description was generated via AI from an annual report. Updated about 1 year ago.